ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?
Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.
Zacks·4d ago
More News
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·6d ago
ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?
ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.
Zacks·10d ago
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.
Zacks·11d ago
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks·12d ago
Intuitive Surgical, Inc. (ISRG) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Intuitive Surgical, Inc. (ISRG) closed at $476.16 in the latest trading session, marking a +1.34% move from the prior day.
Zacks·16d ago
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Zacks·19d ago
ISRG's International Push for Ion: Strategic Bet or Overstretch?
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
Zacks·19d ago
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.
Zacks·25d ago
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story
Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.